The United Kingdom is on high alert as the number of cases of a "mysterious" virus originating from China surged last week.
The report, published yesterday, claimed she qualified for "key worker" status and visited Labour headquarters wearing a face ...
Thick fog shrouded the skyline in Tulsa, Oklahoma, on January 30.
For a while, the opening gambit in a conversation was no longer the weather but whether you’d got the Pfizer, the AstraZeneca or ... one of those crude cloth masks we used But habit has ...
The report, published yesterday, claimed she qualified for "key worker" status and visited Labour headquarters wearing a face mask in December 2020 to advise Sir Keir on how to publicly respond to ...
Over the years, a damaging and misleading picture of Iraq’s business landscape has emerged, which masks both its opportunities ... partners – like AstraZeneca, Pfizer and MSD – to share ...
AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start economic growth”. The drugmaker, which is Britain’s most valuable ...
LONDON, Jan 31 (Reuters) - AstraZeneca (AZN.L), opens new tab on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England ...
A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to address concerns over its business in China than on its earnings report alone.
AstraZeneca says a strong 2024 and stacked pipeline spells potential for further growth in 2025 as the company aims to bring in $80bn in revenue by 2030. CFO Aradhana Sarin outlined AstraZeneca ...
An AstraZeneca and Daiichi Sankyo drug designed to replace chemotherapy was cleared by US regulators for broader use in late-stage breast cancer patients. The Food and Drug Administration ...
AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...